Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

BACKGROUND: Although epidemiological, clinical, and experimental evidence indicates that the inducible isoform of cyclo-oxygenase (COX-2) may be involved in the pathogenesis of several neurodegenerative disorders, the mechanisms whereby COX-2 contributes to Alzheimer's disease are largely unkno...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Combrinck, M, Williams, J, Berardinis, D, Warden, D, Puopolo, M, Smith, A, Minghetti, L
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2006

समान संसाधन

Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease
द्वारा: Minghetti, L, और अन्य
प्रकाशित: (2006)

Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease.
द्वारा: Minghetti, L, और अन्य
प्रकाशित: (2006)

Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.
द्वारा: Belbin, O, और अन्य
प्रकाशित: (2007)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
द्वारा: Belbin, O, और अन्य
प्रकाशित: (2009)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
द्वारा: Oulhaj, A, और अन्य
प्रकाशित: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
द्वारा: Oulhaj, A, और अन्य
प्रकाशित: (2010)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
द्वारा: Appleyard, M, और अन्य
प्रकाशित: (1983)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
द्वारा: Holmes, C, और अन्य
प्रकाशित: (2005)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
द्वारा: Lai, M, और अन्य
प्रकाशित: (2002)

The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline
द्वारा: Smith, M, और अन्य
प्रकाशित: (2000)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
द्वारा: Allen, G, और अन्य
प्रकाशित: (2016)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
द्वारा: Delvenne, A, और अन्य
प्रकाशित: (2024)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
द्वारा: Smith, M, और अन्य
प्रकाशित: (2001)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
द्वारा: Westwood, S, और अन्य
प्रकाशित: (2017)

The soluble transcobalamin receptor (sCD320) in relation to Alzheimer's disease and cognitive scores.
द्वारा: Abuyaman, O, और अन्य
प्रकाशित: (2017)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
द्वारा: Martins, C, और अन्य
प्रकाशित: (2005)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
द्वारा: Nho, K, और अन्य
प्रकाशित: (2018)

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.
द्वारा: De Jager, C, और अन्य
प्रकाशित: (2003)

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
द्वारा: Chance, SA, और अन्य
प्रकाशित: (2011)

Low free testosterone is an independent risk factor for Alzheimer's disease
द्वारा: Hogervorst, E, और अन्य
प्रकाशित: (2004)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
द्वारा: Ballard, C, और अन्य
प्रकाशित: (2005)

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
द्वारा: Bystrom, J, और अन्य
प्रकाशित: (2017)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
द्वारा: Ballard, C, और अन्य
प्रकाशित: (1996)

Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.
द्वारा: Hogervorst, E, और अन्य
प्रकाशित: (2002)

Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.
द्वारा: Hogervorst, E, और अन्य
प्रकाशित: (2003)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (1993)

Serum total testosterone is lower in men with Alzheimer's disease.
द्वारा: Hogervorst, E, और अन्य
प्रकाशित: (2001)

Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models
द्वारा: Shim, Hong Seok, और अन्य
प्रकाशित: (2023)

Low free testosterone is an independent risk factor for Alzheimer's disease.
द्वारा: Hogervorst, E, और अन्य
प्रकाशित: (2004)

Bronchoprotective role for endogenous prostaglandin E2.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (1995)

A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD.
द्वारा: Belbin, O, और अन्य
प्रकाशित: (2008)

Loss of serotonin 5-HT2A receptors in, the temporal cortex correlates with cognitive decline in Alzheimer's disease
द्वारा: Lai, K, और अन्य
प्रकाशित: (2004)

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
द्वारा: Williams, S, और अन्य
प्रकाशित: (2009)

Normal cognitive decline or dementia?
द्वारा: Ebmeier, K
प्रकाशित: (2010)

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
द्वारा: Green, R, और अन्य
प्रकाशित: (2009)

Resolving postoperative neuroinflammation and cognitive decline.
द्वारा: Terrando, N, और अन्य
प्रकाशित: (2011)

Analysing the effect of CSF inflammatory proteins on stroke severity in people with varying severities of Alzheimer's disease
द्वारा: Chan, Shawn Kiat Zhong
प्रकाशित: (2023)

Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men.
द्वारा: Lehmann, D, और अन्य
प्रकाशित: (2003)

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.
द्वारा: Robson, K, और अन्य
प्रकाशित: (2004)

Prostaglandin research /
द्वारा: Crabbe, Pierre
प्रकाशित: (1977)